Skip to main content
. 2020 Oct 30;17(21):7994. doi: 10.3390/ijerph17217994

Table 3.

Overview of key study characteristics.

Source Study Design Country Participants Age Range Aims of Study Substances Targeted
Alemagno et al. (2004) [35] PP USA 59–97 Test efficacy of educational computer programme to reduce medication misuse. Prescription medication & OTC drugs
Barnes et al. (2016) [36] RCT USA 60+ To examine changes in health-related quality of life. Project SHARE interventions vs. TAU Alcohol
Benza et al. (2010) [37] PP USA 60+ To develop and evaluate an educational programme to increase older adults’ knowledge of PSU. Alcohol and OTC drugs
Copeland, Blow, Barry (2003) [38] CS USA 55+ Effect of BI on services use for older veterans who were at-risk drinkers. Alcohol
D’Agostino et al. (2006) [39] RCT USA 51–91 To evaluate the Geriatric Addictions Program (GAP), designed to assist OA with PSU and DD. Alcohol and OTC drugs
Eliason, Skinstad. (2001) [40] PP USA 54–91 Prevalence of AoD interactions in older women and if a BI would change knowledge. Alcohol and OTC drugs
Fink et al. (2005) [41] PCS USA 65+ To evaluate whether providing physicians and older patients in primary care with personalized reports of drinking risks and benefits and patient education reduces alcohol related risks and problems. Alcohol
Fleming et al. (1999) [42] RCT USA 65–75 To test the efficacy of BI in reducing alcohol use in older problem drinkers. Alcohol
Gottlieb Hansen et al. (2012) [43] RCT Denmark 48–65 To test if a BI in a non-treatment seeking population of heavy drinkers results in reduced alcohol intake. Alcohol
Kuerbis et al. (2013) [44] Secondary analysis of data from 3 RCTs USA 54+ Secondary data analysis of cases in three RCT’s that recruited problem drinkers, examining the effectiveness of BI. Additional comparisons to different age cohorts were made. Alcohol
Lee et al. (2009) [45] Secondary analysis of RCT USA 65+ To assess the efficacy of a harm-reduction based intervention to enhance access to treatment and clinical outcomes among elderly at-risk drinkers. Alcohol
McCann, Wadd & Gill Crofts. (2017) [46] QS UK & Norway 46–77 To describe the harm reduction models developed in two wet care homes in England and one in Norway. Alcohol
Oslin et al. (2004) [47] RCT USA 60+ To examine the impact of the Unified Psychogeriatric Biopsychosocial Evaluation and Treatment (UPBEAT) Program, for elderly veterans Alcohol
Oslin et al. (2005) [48] PP USA 50+ To examine differences in the clinical presentation and treatment outcomes of older adults with a diagnosis of alcohol dependence compared to middle-aged adults. Alcohol
Outlaw et al. (2012) [49] PP USA 50+ To determine the effectiveness of the cognitive-behavioral and self-management treatment approaches targeted to older adults. Alcohol, Prescription medication & OTC drugs & ID
Poole et al. (2009) [50] QS Canada 55–70 To review the effect of narrative therapy on OA coping with mental health and PSU. Alcohol
Rao. (2014) [51] CS UK 65–85 To examine the outcomes of an integrated community nursing team for older adults with alcohol misuse. Alcohol
Schonfeld et al. (2015) [52] PP USA Mean age 66.5 Rolling the Florida Brief intervention and treatment for elders (BRITE project) out across 75 different sites. Alcohol and ID
Watson et al. (2013) [53] RCT UK 55+ To compare the clinical effectiveness and cost-effectiveness of a stepped care intervention against a minimal intervention in primary care. Alcohol

Abbreviations: OA, older adults; BI, brief interventions; PSU, problematic substance use; PP, pre-/post design; PCS, Prospective comparison study QE, quasi-experimental design; RCT, randomised control trial; QS, qualitative study; CS, cohort study; TAU, treatment as usual; P & OTC drugs, prescription and over the counter drugs; ID, illegal drugs; DD, dual diagnosis.